Left-right determination factor 1

From WikiMD's WELLNESSPEDIA

(Redirected from LEFTY1)

Left-right determination factor 1 (LRD1) is a protein that plays a crucial role in the development of left-right asymmetry in vertebrates. It is encoded by the LRD1 gene and is involved in the establishment of left-right patterning during embryonic development.

Function[edit]

LRD1 is a transcription factor that regulates the expression of genes involved in left-right patterning. It is primarily expressed in the lateral plate mesoderm, a region of the developing embryo that gives rise to various organs, including the heart and lungs. LRD1 acts as a molecular switch, controlling the activation of genes that specify left-sided structures and repressing genes that specify right-sided structures.

Role in Left-Right Asymmetry[edit]

During early embryonic development, the establishment of left-right asymmetry is crucial for the proper formation and positioning of internal organs. LRD1 is one of the key factors involved in this process. It acts in coordination with other proteins and signaling pathways to ensure that organs are correctly positioned on the left or right side of the body.

Mutations in the LRD1 gene have been associated with various left-right patterning defects in humans and other vertebrates. These defects can lead to a condition known as situs inversus, where the internal organs are mirrored from their normal positions. Additionally, abnormalities in LRD1 expression have been linked to congenital heart defects and other developmental disorders.

Discovery[edit]

LRD1 was first identified as a candidate gene involved in left-right patterning through genetic studies in mice. Further research revealed its conserved role in other vertebrates, including humans. The protein structure and function of LRD1 have been extensively studied to understand its role in left-right determination.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.